Loading...
µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease
Parkinson's disease (PD) is characterized by severe locomotor deficits and is commonly treated with the dopamine precursor L-DOPA, but its prolonged usage causes dyskinesias referred to as L-DOPA–induced dyskinesia (LID). Several studies in animal models of PD have suggested that dyskinesias ar...
Saved in:
| Published in: | J Neurosci |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Society for Neuroscience
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7455220/ https://ncbi.nlm.nih.gov/pubmed/32690616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.0610-20.2020 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|